{
    "eid": "2-s2.0-85068896088",
    "title": "Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel",
    "cover-date": "2018-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Hasseri Halim",
        "Decha Pinkaew",
        "Preedakorn Chunhacha",
        "Patuma Sinthujaroen",
        "Perumal Thiagarajan",
        "Ken Fujise"
    ],
    "citedby-count": 11,
    "ref-count": 78,
    "ref-list": [
        "Long-term use of ticagrelor in patients with coronary artery disease",
        "P2Y(12) inhibitors: Differences in properties and mechanisms of action and potential consequences for clinical use",
        "Pathology of the vulnerable plaque",
        "Ticagrelor versus clopidogrel in patients with acute coronary syndromes",
        "Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy",
        "Novel antiplatelet agents in acute coronary syndrome",
        "Prasugrel versus clopidogrel in patients with acute coronary syndromes",
        "Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease",
        "Long-term use of ticagrelor in patients with prior myocardial infarction",
        "Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo",
        "A potential mechanism of high-dose ticagrelor in modulating platelet activity and atherosclerosis mediated by thymic stromal lymphopoietin receptor",
        "Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis",
        "Ticagrelor: Effects beyond the P2Y12 receptor",
        "Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1",
        "Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome",
        "Adenosine-mediated effects of ticagrelor: Evidence and potential clinical relevance",
        "Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model",
        "Mortality benefit in PLATO cannot be explained by antiplatelet properties of ticagrelor",
        "Effects of P2Y12 receptor antagonists beyond platelet inhibition\u2014comparison of ticagrelor with thienopyridines",
        "Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents",
        "A new platelet function test",
        "Light transmission aggregometry",
        "Assessment of a flow cytometry technique for studying signaling pathways in platelets: Monitoring of VASP phosphorylation in clinical samples",
        "Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets\u2014definition and detection of ticlopidine/clopidogrel effects",
        "Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice",
        "Fortilin reduces apoptosis in macrophages and promotes atherosclerosis",
        "Morelloflavone, a biflavo-noid inhibitor of migration-related kinases, ameliorates atherosclerosis in mice",
        "Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers",
        "Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects",
        "A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet",
        "Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes",
        "Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis",
        "ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice",
        "Lamin proteolysis facilitates nuclear events during apoptosis",
        "Fortilin potentiates the peroxidase activity of Peroxiredoxin-1 and protects against alcohol-induced liver damage in mice",
        "Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation",
        "Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks",
        "Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein",
        "Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study",
        "Rewiring of jasmonate and phytochrome B signalling uncouples plant growth-defense tradeoffs",
        "GARP2 accelerates retinal degeneration in rod cGMP-gated cation channel beta-subunit knockout mice",
        "Protein detection by Simple Western analysis",
        "Failure to recognize novelty after extended methamphetamine self-administration results from loss of long-term depression in the perirhinal cortex",
        "Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers",
        "Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with mild hepatic impairment",
        "Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment",
        "Ticagrelor: Pharmacokinetics, pharmacodynamics, clinical efficacy, and safety",
        "Adenosine and ticagrelor plasma levels in patients with and without ticagrelor-related dyspnea",
        "Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression",
        "JNK1 deficiency in hematopoietic cells suppresses macrophage apoptosis and increases atherosclerosis in low-density lipoprotein receptor null mice",
        "Interleukin-6 exacerbates early atherosclerosis in mice",
        "Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromso study",
        "Macrophage inflammatory protein-1beta and fibrino-gen are synergistic predictive markers of prognosis of intermediate coronary artery lesions",
        "Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells",
        "Chemokine CXCL10 promotes athero-genesis by modulating the local balance of effector and regulatory T cells",
        "Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans",
        "Tumor necrosis factor-alpha in human arterial wall with atherosclerosis",
        "Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha",
        "Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice",
        "Targeting paraoxonase-1 in atherosclerosis",
        "Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression",
        "Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis",
        "Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques",
        "Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis",
        "Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis",
        "Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice",
        "Detection and localization of tumor necrosis factor in human atheroma",
        "Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells",
        "Identification of active tissue factor in human coronary atheroma",
        "Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice",
        "Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression",
        "Pro-inflammatory role of platelets in hypertension-mediated end-organ damage: Editorial to: \"Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis",
        "Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis",
        "Atherosclerotic plaque rupture\u2014pathologic basis of plaque stability and instability",
        "Cell death and diseases related to oxidative stress: 4-hydro-xynonenal (HNE) in the balance",
        "Platelet P2Y12 receptor inhibition by thienopyridines: Status and future",
        "Hepatocellular toxicity of clopidogrel: Mechanisms and risk factors",
        "The mechanism and risk factors of clopidogrel-induced liver injury"
    ],
    "affiliation": [
        {
            "affiliation-city": "Galveston",
            "@id": "60014569",
            "affilname": "UT Medical Branch at Galveston",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014569",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Galveston",
            "@id": "60017552",
            "affilname": "University of Texas Medical Branch, School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017552",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Shah Alam",
            "@id": "60004351",
            "affilname": "Universiti Teknologi MARA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004351",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60002441",
            "affilname": "Baylor College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002441",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "University of Cincinnati Metabolic Diseases Institute",
        "National Institutes of Health",
        "National Heart, Blood",
        "National Institute of Diabetes and Digestive and Kidney Diseases",
        "American Heart Association",
        "AstraZeneca"
    ]
}